Page last updated: 2024-11-13

4-hydroxyospemifene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID22504506
SCHEMBL ID5738276
MeSH IDM0573295

Synonyms (8)

Synonym
SCHEMBL5738276
ospemifene metabolite m1
(z)-4-(1-(2-chloroethyl)-2-(4-(2-hydroxyethoxy)phenyl)-2-phenylvinyl)phenol
MZC9KS3HJL ,
341525-22-2
phenol, 4-((4z)-3-chloro-1-((4-(2-hydroxyethoxy)phenyl)phenylmethylene)propyl)-
4-hydroxyospemifene
unii-mzc9ks3hjl

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The clinical pharmacokinetic findings and in vitro data suggest that CYP3A4 is important for ospemifene metabolism, but other CYP isoforms and metabolic pathways also contribute."( Effects of cytochrome P450 inhibitors and inducers on the metabolism and pharmacokinetics of ospemifene.
Lammintausta, R; Lehtinen, T; Pelkonen, O; Scheinin, M; Tolonen, A; Turpeinen, M; Uusitalo, J; Vuorinen, J, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"To assess the effect of concomitant food intake on the relative bioavailability of ospemifene and its main metabolite, 4-hydroxyospemifene, after single oral dosing."( Oral bioavailability of ospemifene improves with food intake.
Aaltonen, AM; Katila, K; Koskimies, P; Lammintausta, R; Saarni, O; Scheinin, M; Vuorinen, J, 2013
)
0.6
" The increase in bioavailability was not linearly related with the fat content of the meal."( Oral bioavailability of ospemifene improves with food intake.
Aaltonen, AM; Katila, K; Koskimies, P; Lammintausta, R; Saarni, O; Scheinin, M; Vuorinen, J, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" In this study, we test the effects of three dosing levels of ospemifene in both the prevention and treatment of breast cancer in the MTag."( Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.
Bell, KE; Burich, RA; DeGregorio, MW; Greenberg, BE; Griffey, SM; McCall, JL; Mehta, NR; Wurz, GT, 2012
)
0.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]